Which science field has the most promising future?

Computer science
Nanotechnology
Biotechnology
Aerospace engineering
Ecology, resource saving
Cleantech
Other

What is the mankind's most dangerous invention?

Atomic bomb
Drugs
Automobile
Money
Television
Fast food
Internet

Innovation by Russian scientists will help ease cancer treatment

Around the world, more than 12 million people each year are diagnosed with cancer. In the age of high technology, it still remains one of the most difficult diseases to treat. A device developed by young Russian scientists will make it easier for patients to endure chemotherapy and help physicians achieve better results faster.

Chemotherapy – one of the main methods for treating cancer patients – is hard for many patients to get through and often has adverse health effects. Young Russian scientists at InErPharm are ready to offer a breakthrough solution: their in-house development CytoDel reduces the toxicity of medications and increases the therapeutic effect of treatment.

“CytoDel is a device that draws blood, isolates erythrocytes, injects them in an anticancer agent and returns them back to the blood flow. In other words, erythrocytes act as carriers of medications,” says InErPharm director biophysicist Nikolai Ivanov.

The procedure takes 90 minutes. After that, the patient is injected with their own blood containing erythrocytes and the anticancer agent. Treated red blood cells tend to discharge medication for longer periods of time, thus enabling physicians to avoid peak doses of the drug while keeping its concentration at a level required for therapeutic effect. Furthermore, this method requires fewer injections of chemical agents.

InErPharm is a relatively young company, being registered on 9 January 2012 and beginning full-scale operations in May of that year. The InErPharm team is comprised of six graduates of Moscow universities led by professor Fazly Ataullakhanov. InErPharm is looking to apply for Skolkovo residency soon.

“The idea of using red blood cells as carriers of physiologically active substances is by no means new. The first research papers exploring this possibility date back to the 1950s and were originally written by western scientists. In vivo tests were performed on mice and dogs mostly for scientific purposes. The laboratory run by our research advisor Fazly Ataullakhanov enabled us to perform the first tests on humans, and they showed good results,” says Nikolai Ivanov.

The test was performed on high-risk cancer patients with stage III and IV cancer and unresponsive to standard chemotherapy. In most cases, the test showed an absence of tachycardia, cardiotoxicity and myelosuppression – the principle side effects of chemotherapy. In some cases, physicians reported a marked decline in those side effects and remission. “The physicians noted that the patients did indeed feel better,” Ivanov says.

The device has not been tested in pre-clinical or clinical studies yet, but the InErPharm team has already won awards in some major business project competitions, including Startup Village 2013, organised by the Russian Skolkovo Innovation Center, and two competitions held by the Russian Venture Company: BIT-2012 and HSE{10K}-2012. It was also one of the eight finalists of the 2012 Intel Global Challenge at UC Berkeley. The project is backed by the Fund for Assistance to Small Innovative Enterprises in Science and Technology.

Two more companies – France’s ErytechPHARMA and Italy’s EryDel – are currently promoting the technology of using red blood cells as carriers of physiologically active substances in the world market. The former was established about 12 years ago and has just entered the US market for the treatment of pancreatic cancer and leukemia.

The InErPharm researchers hope that their solution will interest their western counterparts. It is planned that the device will primarily target lung cancer treatment. It will take at least three or four years for InErPharm to start marketing the device. 

2013-09-23, Russia Beyond The Headlines, Maria Salkhani.


Keywords: innovations, medicine and healthcare, science, devices

23.09.2013
Innovation by Russian scientists will help ease cancer treatment
20.09.2013
The sky's the limit as Google takes a 'moonshot' at health with Calico
20.09.2013
E-readers may help dyslexics read more easily
19.09.2013
Russia's Skolkovo Project Will Have To Overcome Toxic Bureaucracy If It Wants To Compete With Silicon Valley
19.09.2013
US entrepreneur takes charge of Lobachevsky University innovation to propel Nizhny Novgorod to global recognition
18.09.2013
Six Ig Nobel Prize awards received by Russians
18.09.2013
Guinness Record: World’s Thinnest Glass Is Just Two Atoms Thick
18.09.2013
Cisco and Skolkovo named winners of the I-PRIZE contest
18.09.2013
At Stanford, Russian and his colleagues turn DNA into basis for carbon transistors
18.09.2013
Business incubator of Moscow Institute of Physics and Technology started its work
13.09.2013
Breakthrough by Russian scientists will help newborns
13.09.2013
‘Russian Innovation Week’ to Boost US-Russia High-Tech Ties
13.09.2013
St. Pete’s Sensor Systems raises $1m for its ‘electronic tongue’
12.09.2013
Business angels will discuss strategy of innovations support in Russia
11.09.2013
Anger Issues? Russian Scientists Have an App for That

Leave your comment
Sign up
Enter verification codeEnter verification code

Second Moscow International Foreign Investment Forum
Most popular news
Annual Investment Meeting 2013

Welcome to Investment. Innovation. Business Web Portal – a community-driven platform for all the participants of the investment process both in Russia and abroad!

We work to provide online information exchange between Russian and global investors and innovators, business owners and developers.